One of the most promising cancer treatments is cell therapy. Extracorporeal cell therapies involve removing cells from the patient and sending them to a lab for treatment before reimplanting them into the patient. This is a high-risk supply chain process. German-based Camelot ITLab has created a blockchain solution.
“Since highly innovative extracorporeal cell therapies are often the last hope for many patients, there is no room for error in the entire process. That is why we have come up with a digital application that not only ensures maximum data-sharing and data-storage security, but also focuses on the patient,” said Dr. Josef Packowski, CEO of CAMELOT Consulting Group
The blockchain solution aims to make sure the right cells are returned to the right patients. According to the company, “all data transactions take place exclusively between verified participants and are immutably and consistently stored by means of encryption in the blockchain”.
Article continues …
Want the full story? Pro subscribers get complete articles, exclusive industry analysis, and early access to legislative updates that keep you ahead of the competition. Join the professionals who are choosing deeper insights over surface level news.
